Skip to main navigation

Skip to content

Newsroom
Join our team

About us
Our purpose
Our culture
Products & pipeline
Investors

About us
Our purpose
Our culture
Products & pipeline
Investors

Newsroom
Join our team

About us
Our purpose
Our culture
Products & pipeline
Investors

Newsroom
Join our team

Dashboard
Press releases
Quarterly results
Financials & filings
Events & presentations
Stock information
Analyst coverage
Corporate governance
Investor FAQs

Search for:

Press releases

Press releases

Year

Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg

November 23, 2020

Adamas to Present at Upcoming Piper Sandler Conference

November 18, 2020

Adamas Announces New Employment Inducement Grant

November 13, 2020

Adamas Reports Third Quarter 2020 Financial Results

November 5, 2020

Adamas announces settlement agreement of previously disclosed class action litigation

November 2, 2020

Adamas to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020

October 26, 2020

Adamas Announces New Employment Inducement Grant

October 9, 2020

Adamas appoints new Chief Medical Officer, Adrian Quartel, MD

October 1, 2020

Adamas Announces New Employment Inducement Grant

September 11, 2020

Adamas presents new post-hoc data analysis for GOCOVRI® in Parkinson’s disease patients with dyskinesia at the 2020 Movement Disorder Society Virtual Congress

September 11, 2020

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Quick links

Email alerts
Quarterly results

Annual reports
Investor contact

Connect with us

Contact us
Privacy policy
Online tracking opt-out guide
Terms of use
Site map

© 2020 Copyright Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved.

© 2020 Copyright Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved.